Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 8.41 Delayed Data As of Apr 03 |  +0.29 / +3.57%Today’s Change | 6.07 Today|||52-Week Range 15.72 | -14.18% Year-to-Date |
Stock Price Forecast
The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a +42.69% increase from the last price of 8.41.
Analyst Recommendations
The current consensus among 23 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since March, when it was unchanged from a rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
$0.58
$0.58
Sales
$4.1B
$4.1B
Reporting Date
Apr 30
Apr 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -6.13%
Growthannually 1.81%
Sales
Growthquarterly -7.33%
Growthannually -0.74%
